Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

UserTweets
@AmericanBanking 9
@Gambiste1 8
@Tickeron 6
@newsfilterio 5
@OlympiaReport 4

Recent Tweets for ADMS

TopStockAlerts1 @TopStockAlerts1
$ADMS Liking it for a swing!
November 10th 2019, 4:11pm
ConsumerFeed @ConsumerFeed
Adamas Pharmaceuticals $ADMS Earns Buy Rating from Northland Securities https://t.co/PdW4fruVVL
November 10th 2019, 4:11pm
bbnsnews @bbnsnews
Adamas Pharmaceuticals $ADMS Rating Reiterated by Northland Securities https://t.co/btXDuojPyN
November 10th 2019, 4:11pm
BlueBioNow @BlueBioNow
$ADMS might be worth taking a position when this bottoms 19.79 % change recently https://t.co/XRyA8PlkjA
November 10th 2019, 2:11pm
OlympiaReport @OlympiaReport
Adamas Pharmaceuticals $ADMS Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS https://t.co/Zw9C74aKvK
November 10th 2019, 1:11pm
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals $ADMS Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS https://t.co/8tuhwg6Mnp
November 10th 2019, 1:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: 25,000 shares acquired by Prentiss Christopher B (Chief Financial Officer) $ADMS https://t.co/snek0G7SNk
November 10th 2019, 3:11am
newsfilterio @newsfilterio
25,000 shares acquired by Prentiss Christopher B (Chief Financial Officer) $ADMS https://t.co/snek0G7SNk
November 10th 2019, 2:11am
WatchlistN @WatchlistN
Adamas Pharmaceuticals $ADMS Given “Buy” Rating at Northland Securities https://t.co/rc9Kz1bYPH
November 10th 2019, 12:11am
Gambiste1 @Gambiste1
RT @newsfilterio: Adamas Pharma EPS misses by $0.11, misses on revenue $ADMS https://t.co/gEKPw1Tm2G
November 9th 2019, 11:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: Mixed shelf roundup - healthcare $ADMS $DRNA https://t.co/RgOZMZwBtb
November 9th 2019, 11:11pm
WatchlistN @WatchlistN
Adamas Pharmaceuticals $ADMS Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS https://t.co/zvJCzg9avM
November 9th 2019, 6:11pm
WeekHerald @WeekHerald
Adamas Pharmaceuticals $ADMS Stock Price Up 5.4% https://t.co/puxe97BC5s
November 9th 2019, 5:11pm
OlympiaReport @OlympiaReport
Adamas Pharmaceuticals $ADMS Trading 5.4% Higher https://t.co/07Oioo0t76
November 9th 2019, 5:11pm
ZolmaxNews @ZolmaxNews
Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/NtRbRSzttY
November 9th 2019, 5:11pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/aXvssFVftQ #stocks
November 9th 2019, 1:11pm
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals $ADMS Announces Earnings Results https://t.co/TSESPpAahu
November 9th 2019, 1:11pm
TickerReport @TickerReport
Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/cQqkTeWjHd
November 9th 2019, 1:11pm
Gambiste1 @Gambiste1
RT @gcassidy718: $ADMS reasonable changes in stock price 19.79 % change recently https://t.co/dvflrsAT2L
November 9th 2019, 11:11am
gcassidy718 @gcassidy718
$ADMS reasonable changes in stock price 19.79 % change recently https://t.co/dvflrsAT2L
November 9th 2019, 11:11am
BlueBioNow @BlueBioNow
$ADMS Stock is under performing. . . -3.62 % change recently https://t.co/XRyA8PlkjA
November 8th 2019, 11:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: Adamas Reports Third Quarter 2019 Financial Results $ADMS https://t.co/sCgBTTg5Wu
November 8th 2019, 10:11pm
ChartMill @ChartMill
$ADMS has a better Quick Ratio than the average industry Quick Ratio of 4.90 https://t.co/L4kBwCLi6i https://t.co/M5povTDTTb
November 8th 2019, 6:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: Adamas Announces New Employment Inducement Grant $ADMS https://t.co/u8UpjnB2kG
November 8th 2019, 6:11pm
fm23 @fm23
$ADMS https://t.co/ySNmXIq25F
November 8th 2019, 5:11pm
InsiderAlertsIA @InsiderAlertsIA
$ADMS: New Insider Filing on Chief Financial Officer CHRISTOPHER B PRENTISS: https://t.co/LOHjLWVz25
November 8th 2019, 5:11pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS PT Lowered to $16.00 at JMP Securities https://t.co/defHZKtJQu #stocks
November 8th 2019, 4:11pm
WatchlistN @WatchlistN
Adamas Pharmaceuticals $ADMS PT Lowered to $16.00 https://t.co/DzUFqwXEIu
November 8th 2019, 4:11pm
otcdynamics @otcdynamics
$ADMS Adamas Announces New Employment Inducement Grant https://t.co/ntU3TsGAAE
November 8th 2019, 4:11pm
newsfilterio @newsfilterio
Adamas Announces New Employment Inducement Grant $ADMS https://t.co/u8UpjnB2kG
November 8th 2019, 4:11pm
newsfilterio @newsfilterio
Mixed shelf roundup - healthcare $ADMS $DRNA https://t.co/RgOZMZwBtb
November 8th 2019, 3:11pm
ramypandey @ramypandey
$adms from LOD to HOD is more than 40%. Wow
November 8th 2019, 2:11pm
LargeVoidBot @LargeVoidBot
14:24 Pops: $ADMS +3.7%
November 8th 2019, 2:11pm
nodramahere7 @nodramahere7
$ADMS Nice pop here on strong volume!
November 8th 2019, 1:11pm
marketexclusive @marketexclusive
$ADMS Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Hold rating reiterated by Needham & Company LLC https://t.co/GSduKD9aBR #stocks
November 8th 2019, 1:11pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals’ $ADMS “Hold” Rating Reaffirmed at Needham & Company LLC https://t.co/Ew2i9xtjKx #stocks
November 8th 2019, 1:11pm
newsfilterio @newsfilterio
Adamas Pharma EPS misses by $0.11, misses on revenue $ADMS https://t.co/gEKPw1Tm2G
November 8th 2019, 12:11pm
ramypandey @ramypandey
Interesting run in $adms. Watching
November 8th 2019, 11:11am
LargeVoidBot @LargeVoidBot
10:36 Drops: $ADMS -6.0%
November 8th 2019, 10:11am
Gambiste1 @Gambiste1
RT @Biotrade_alert: Trade Alert: Sold $ADMS at $4.32 with 1% Gain (2% Position)
November 8th 2019, 10:11am
Biotrade_alert @Biotrade_alert
Trade Alert: Sold $ADMS at $4.32 with 1% Gain (2% Position)
November 8th 2019, 9:11am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS Stock Rating Reaffirmed by Northland Securities https://t.co/mLA2LjWlMU #stocks
November 8th 2019, 9:11am
AnalystWire @AnalystWire
Adamas Pharmaceuticals $ADMS PT Lowered to $11 at Piper Jaffray https://t.co/Dr3jz2R2M5
November 8th 2019, 9:11am
marketexclusive @marketexclusive
$ADMS Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Northland Securities with a $15.00… https://t.co/u7XazZp58i
November 8th 2019, 8:11am
TickerReport @TickerReport
Northland Securities Reaffirms Buy Rating for Adamas Pharmaceuticals $ADMS https://t.co/D7tbF0UhJX
November 8th 2019, 8:11am
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals’ $ADMS Buy Rating Reiterated at Northland Securities https://t.co/aBYD6zXBo1
November 8th 2019, 8:11am
Gambiste1 @Gambiste1
RT @Tickeron: $ADMS's 10-day Moving Average broke below its 50-day Moving Average on October 3, 2019. View odds for this and other indicato…
November 8th 2019, 5:11am
Tickeron @Tickeron
$ADMS's 10-day Moving Average broke below its 50-day Moving Average on October 3, 2019. View odds for this and othe… https://t.co/DPO4NwnmW4
November 8th 2019, 4:11am
newsfilterio @newsfilterio
Adamas Reports Third Quarter 2019 Financial Results $ADMS https://t.co/sCgBTTg5Wu
November 8th 2019, 12:11am
newswelldone @newswelldone
$ADMS: Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 …: https://t.co/u8dpFNNOw6
November 7th 2019, 10:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.